Literature DB >> 27100481

Progress in research and application of PLGA embolic microspheres.

Shilong Han1, Xiaoping Zhang2, Maoquan Li3.   

Abstract

Transcatheter arterial chemoembolization was an important method in the treatment of solid cancers and the effectiveness of such treatment depends on the nature of embolic agent. Due to the biocompatibility, controllable degradation rate, and both hydrophobicity-hydrophilicity, researches of application on poly(lactic-co-glycolic acid) (PLGA) in medical practice has been ongoing for more than 40 years. We have seen many benefits for patients in recent years. There were five different methods of preparing micrometer-scale microspheres, and three kinds of PLGA microspheres have been subjected to experimental research or used in clinical applications, namely blank microspheres, drug-loaded microspheres, and radioactive microspheres. Hereby, we reviewed the production and clinical and experimental applications of PLGA microspheres in practice.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27100481     DOI: 10.2741/4430

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  4 in total

Review 1.  Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Guorong Jia; Juno Van Valkenburgh; Austin Z Chen; Quan Chen; Jindian Li; Changjing Zuo; Kai Chen
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-08-17

2.  Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma.

Authors:  Yi Gao; Yue Zhu; Xiaopeng Xu; Fangjun Wang; Weidong Shen; Xia Leng; Jiyi Zhao; Bingtuan Liu; Yangyun Wang; Pengfei Liu
Journal:  Front Cell Dev Biol       Date:  2021-07-27

3.  Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.

Authors:  Pengkai Ma; Jianhua Chen; Haixian Qu; Ye Li; Xiaohui Li; Xuemei Tang; Zhigang Song; Hainan Xin; Jinbang Zhang; Jingxue Nai; Zhiping Li; Zhijun Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

4.  Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans.

Authors:  Takeshi Mori; Miyako Yoshida; Mai Hazekawa; Daisuke Ishibashi; Yoshiro Hatanaka; Toshihiro Nagao; Rie Kakehashi; Honami Kojima; Rio Uno; Minoru Ozeki; Ikuo Kawasaki; Taku Yamashita; Junichi Nishikawa; Takahiro Uchida
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.